XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 643,700,000 $ 609,200,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Restructuring charges 0 1,600,000
Income from equity method investments (5,800,000) (6,100,000)
Dividends from affiliates 6,100,000 2,500,000
Provision for credit (gains) losses (1,800,000) 4,600,000
Unrealized losses (gains), net on derivative contracts 2,300,000 (6,700,000)
Stock-based compensation expense 20,800,000 20,100,000
Employee stock purchase plan discount 400,000 0
Depreciation and amortization 79,400,000 69,600,000
Deferred income taxes 22,200,000 (21,500,000)
Pension expense 3,200,000 3,500,000
Pension contributions (6,100,000) (9,100,000)
Changes in assets and liabilities, net of effects of acquisitions and divestitures:    
Accounts and notes receivable (94,700,000) (229,100,000)
Inventories (284,200,000) 9,100,000
Other current assets (7,000,000.0) 0
Accounts payable (16,700,000) 104,600,000
Accrued expenses (37,300,000) 31,300,000
Income taxes payable and receivable, net 27,700,000 20,400,000
Leases, net 5,200,000 3,800,000
Other, net (5,700,000) 8,700,000
Net cash provided by operating activities 351,700,000 613,300,000
Cash flows from investing activities:    
Proceeds from the disposal of property, plant and equipment 1,100,000 1,900,000
Purchases of property, plant and equipment (89,600,000) (103,400,000)
Net proceeds from previous disposition 0 4,100,000
Acquisitions, net of cash 0 1,800,000
Proceeds from (purchases of) investments and other 900,000 (12,500,000)
Net cash used in investing activities (87,600,000) (108,100,000)
Cash flows from financing activities:    
Commercial paper borrowings 677,100,000 424,100,000
Commercial paper payments (520,100,000) (574,100,000)
Borrowings from debt arrangements 0 156,700,000
Payments on debt arrangements (14,200,000) (190,200,000)
Payment of senior unsecured notes (300,000,000.0) 0
Payments of deferred financing costs (1,700,000) 0
Proceeds from employee stock purchases 4,000,000.0 3,300,000
Repurchases of common stock (331,800,000) (12,900,000)
Repurchases of common stock to satisfy employee withholding tax obligations (13,300,000) (15,000,000.0)
Cash dividends paid (127,400,000) (119,300,000)
Net cash used in financing activities (627,400,000) (327,400,000)
(Decrease) increase in cash and cash equivalents (363,300,000) 177,800,000
Effect of exchange rates on cash and cash equivalents 1,100,000 4,600,000
Cash and cash equivalents, beginning of period 415,100,000 60,700,000
Cash and cash equivalents, end of period 52,900,000 243,100,000
Supplemental disclosures of cash flow information:    
Interest paid 39,700,000 44,700,000
Income taxes paid (net of refunds) $ 91,500,000 $ 145,500,000